AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cardinal Health Stock Drops 7% Amid Acquisition and Q4 Earnings
ByAinvest
Tuesday, Aug 12, 2025 5:14 pm ET1min read
Cardinal Health stock fell 7% after announcing a $1.9 billion acquisition of Solaris Health, a urology MSO, and reporting flat Q4 revenue at $60.2 billion. Non-GAAP net income rose 11% to $501 million, or $2.08 per share. The company raised its 2026 guidance, forecasting adjusted EPS of $9.30 to $9.50.
Cardinal Health (NYSE: CAH) reported its fourth quarter (Q4) and full year (FY) 2025 results, with stock falling 7% after the announcement of a $1.9 billion acquisition of Solaris Health, a leading urology medical services organization (MSO). The company's Q4 revenue was relatively flat at $60.2 billion, while non-GAAP net income rose 11% to $501 million, or $2.08 per share. Cardinal Health also raised its 2026 earnings per share (EPS) guidance to $9.30 to $9.50 [1].Financial Highlights:
- Revenue: Q4 revenue was $60.2 billion, a 2% decrease from the previous year. Excluding the impact of a previously communicated customer contract expiration, revenue increased by 21% [1].
- Operating Earnings: GAAP operating earnings were $428 million, a 7% increase year-over-year (YoY). Non-GAAP operating earnings rose 19% to $719 million [1].
- EPS: GAAP diluted EPS was $1.00, while non-GAAP diluted EPS increased 13% to $2.08 [1].
- Acquisition: Cardinal Health announced the acquisition of Solaris Health, which will join the Specialty Alliance's Urology Alliance [1].
Stock Performance:
Cardinal Health's stock fell 7% after the announcement, with investors reacting to the acquisition's cost and the flat Q4 revenue. The company's shares traded at $120.50, down from $130.00 before the announcement.
Outlook:
Cardinal Health raised its 2026 non-GAAP EPS guidance to $9.30 to $9.50, a 13% to 15% increase from the previous guidance. The company expects revenue growth of 11% to 13% for the Pharmaceutical and Specialty Solutions segment, 2% to 4% for the Global Medical Products and Distribution segment, and 26% to 28% for the Other segment [1].
References:
[1] https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet